Vitamin D in Chronic Kidney DiseasePablo A. Ureña Torres, Mario Cozzolino, Marc G. Vervloet Springer, 2016 M09 21 - 574 páginas Vitamin D deficiency, circulating levels lower than 15 ng/ml, is an epidemic disease worldwide with more than a billion people suffering of it in the beginning of the 21-century. Besides its impact on mineral and bone metabolism, these low vitamin D levels are also associated with a diversity of non-skeletal complications, among them cardiovascular disease, diabetes mellitus, multiple sclerosis, cancer, tuberculosis, and immune system dysfunction. Chronic Kidney Disease is also a very common disease, affecting more than 10% of the world population, ranging from stage 1 to stage 5 before dialysis. Approximately 1% of the population in industrialized countries is affected by end-stage renal disease (ESRD), needing a renal replacement therapy either hemodialysis or peritoneal dialysis, and ultimately by renal transplantation. Those CKD patients are more susceptible to exhibit reduced vitamin D stocks. Consequently, more than eighty percent of CKD patients have either insufficient or deficient vitamin D levels for multiple reasons. |
Contenido
2 | |
Classical Mineral and Bone Effects | 129 |
Nonclassical Effects of Vitamin D | 246 |
Kidney Transplantation | 421 |
563 | |
Otras ediciones - Ver todas
Vitamin D in Chronic Kidney Disease Pablo A. Ureña Torres,Mario Cozzolino,Marc G. Vervloet Sin vista previa disponible - 2018 |
Vitamin D in Chronic Kidney Disease Pablo A. Ureña Torres,Mario Cozzolino,Marc G. Vervloet Sin vista previa disponible - 2016 |
Términos y frases comunes
25-hydroxyvitamin 25(OH)D levels active vitamin Alfacalcidol associated binding Biol Bone Miner calcification calcitriol calcium cardiac CaSR cells cholecalciferol chronic kidney disease cinacalcet CKD patients CKD stage CKD-MBD clinical decreased diabetes dialysis patients dose effects of vitamin eGFR endothelial ergocalciferol ESRD fibroblast growth fractures function hemodialysis hemodialysis patients hypercalcemia hyperphosphatemia hypertension increased inflammation inhibition insulin intestinal JAm Soc Nephrol Kidney Int meta-analysis mice mineral metabolism mortality muscle Nephrol Dial Transplant ng/mL Nutr osteoblasts outcomes parathyroid glands parathyroid hormone paricalcitol pathway patients with CKD phosphate placebo plasma protein proteinuria PTH levels PTH1R randomized rats RCTs reduced regulation renal failure renal transplant role sclerostin secondary hyperparathyroidism serum PTH SHPT soluble klotho studies therapy tion tissue transcription uremic vascular calcification VDR activation VDRE vitamin D analogs vitamin D deficiency vitamin D levels vitamin D metabolism vitamin D receptor vitamin D status vitamin D supplementation vitamin D treatment vitamin D3